11-108272572-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP2_StrongBA1BP4

This summary comes from the ClinGen Evidence Repository: The ATM c.3118A>G (p.Met1040Val) variant has a GnomAD (v2.1.1) filtering allele frequency of 4.2% (AFR) which is above the ATM BA1 threshold of 0.5% (BA1). This variant has been observed in a homozygous state in multiple individuals without Ataxia-Telangiectasia (BP2_Strong, GTR Lab IDs: 500031, 61756). In silico protein predictors (BayesDel, score:-0.45, AGVGD, Class C0) predict that this alteration is not deleterious (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA151920/MONDO:0016419/020

Frequency

Genomes: 𝑓 0.011 ( 37 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 30 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

17

Clinical Significance

Benign reviewed by expert panel P:1B:29O:1

Conservation

PhyloP100: 0.350

Publications

22 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.3118A>Gp.Met1040Val
missense
Exon 21 of 63NP_000042.3
ATM
NM_001351834.2
c.3118A>Gp.Met1040Val
missense
Exon 22 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.3118A>Gp.Met1040Val
missense
Exon 21 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.3118A>Gp.Met1040Val
missense
Exon 22 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.3118A>Gp.Met1040Val
missense
Exon 21 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1740
AN:
152220
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0398
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00307
AC:
772
AN:
251290
AF XY:
0.00225
show subpopulations
Gnomad AFR exome
AF:
0.0426
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00112
AC:
1640
AN:
1461446
Hom.:
30
Cov.:
32
AF XY:
0.000949
AC XY:
690
AN XY:
727044
show subpopulations
African (AFR)
AF:
0.0397
AC:
1327
AN:
33446
American (AMR)
AF:
0.00203
AC:
91
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39634
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111726
Other (OTH)
AF:
0.00293
AC:
177
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
80
161
241
322
402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1744
AN:
152338
Hom.:
37
Cov.:
32
AF XY:
0.0111
AC XY:
824
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0397
AC:
1652
AN:
41578
American (AMR)
AF:
0.00464
AC:
71
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68034
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00369
Hom.:
34
Bravo
AF:
0.0132
ESP6500AA
AF:
0.0402
AC:
177
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00371
AC:
451
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
12
not specified (13)
-
-
6
not provided (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
Ataxia-telangiectasia syndrome (3)
-
-
1
ATM-related cancer predisposition (1)
1
-
-
B-cell non-Hodgkin lymphoma (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Familial cancer of breast (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
4.4
DANN
Benign
0.35
DEOGEN2
Benign
0.045
T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.49
N
PhyloP100
0.35
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.21
N
REVEL
Benign
0.096
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.083
MVP
0.65
MPC
0.13
ClinPred
0.0014
T
GERP RS
-1.1
Varity_R
0.12
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3092857; hg19: chr11-108143299; COSMIC: COSV53737085; COSMIC: COSV53737085; API